Plasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience.

about

Thrombotic microangiopathy: expanding genetic, clinical and therapeutic spectra and the need for worldwide implementation of recent advances Changing Trends in Therapeutic Plasmapheresis: An Indian Perspective.

P2860

Q36306802-3C13476B-50E6-4BE5-A43C-4A740FF5E6A2 Q47998571-E33DA3FE-1FF1-4495-A372-6187FAE1005E

P2860

Plasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience.

Item

http://www.wikidata.org/entity/Q36306747

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Plasma exchange for paediatric ...... s: a single-centre experience.

@ast

Plasma exchange for paediatric ...... s: a single-centre experience.

@en

type

Item

label

Plasma exchange for paediatric ...... s: a single-centre experience.

@ast

Plasma exchange for paediatric ...... s: a single-centre experience.

@en

prefLabel

Plasma exchange for paediatric ...... s: a single-centre experience.

@ast

Plasma exchange for paediatric ...... s: a single-centre experience.

@en

P1476

Plasma exchange for paediatric ...... s: a single-centre experience.

@en

P2093

Afsana Jahan

http://www.w3.org/2001/XMLSchema#string

Indira Agarwal

http://www.w3.org/2001/XMLSchema#string

Sudheer Kumar Reddy

http://www.w3.org/2001/XMLSchema#string

Swasti Chaturvedi

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.

Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.

Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Complications of apheresis in children.

Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone.

Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence.

P304

702-707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CKJ/SFV084

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281627337

http://www.w3.org/2001/XMLSchema#string

P698

26613028

http://www.w3.org/2001/XMLSchema#string

P932

4655793

http://www.w3.org/2001/XMLSchema#string

Plasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience.

about

P2860

P2860

Plasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932